Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB.TO) received a increase from Health Canada right this moment, with information that can assist the corporate scale up manufacturing.

Two Aurora services absolutely licensed

The Edmonton-based firm introduced this morning that Health Canada awarded full licensing to its Aurora Sky and MedReleaf Bradford services.

Facilities to supply and promote hashish

The Edmonton and Bradford services are actually licensed to supply and promote hashish and its spinoff merchandise.

Scaling provide

According to Aurora’s CEO, Terry Booth, the increase to the corporate’s manufacturing capability will likely be vital.

“The Sky and Bradford facilities specifically add over 128,000 kg per year in capacity.” That, he says, will lead to “significant increases in product availability across our domestic medical and consumer.”

He added that this can add to provide for the worldwide market segments as properly within the coming months.

Booth credit Aurora’s manufacturing prowess for the corporate’s success at its Aurora Sky facility.

“Current production at Aurora Sky, with recent harvests exceeding target yields, validates our production philosophy and our investment in high-tech, highly automated facilities.”

He continued, “MedReleaf Bradford employs best practices identified during the integration of the Aurora and MedReleaf organizations, and is consistently delivering exceptional yields and high-quality product [to]… medical and consumer markets.”

Flying pleasant skies

Aurora is understood for its value effectivity. The Aurora Sky facility was created to supply excessive caliber, constant hashish at a low value.

The facility is 800,000 sq. toes, makes use of state-of-the-art expertise, and focuses on automation. The objective is spectacular: lower than a buck to supply a gram of weed.

Following this morning’s information, Aurora expects the plant to be totally seeded by subsequent month.

Rooms to develop

The MedReleaf Bradford facility is equally engineered to impress. At 210,000 sq. toes, Aurora constructed the high-tech facility to EU GMP specs. 17 individually climate-controlled plant rooms home hang-dried, hand-manicured hashish.

The firm predicts early April 2019 to have the power absolutely planted. It expects to domesticate 28,000 kg of marijuana yearly from the power.

Is Aurora a purchase?

Aurora’s personal estimates high 500,000 kg annual manufacturing. However, the corporate is in a superb place to beat opponents at its peak manufacturing.

Consider its natural development with Aurora Sky and Aurora Sun services, its partnership with Aurora Nordic, and its acquisitions like ICC Labs, CanniMed and MedReleaf. Those services could push manufacturing above estimates, and hearty provide offers might observe.

Nevertheless, buyers should additionally remember that the corporate’s excellent shares went from 16 million to 998.5 million lately. While the acquisitions deliver the corporate worth, that dilution hurts shareholders.

Meanwhile, Health Canada’s licensing fee, in addition to provide chain bottlenecks are nonetheless a concern for producers there. On the corporate’s current earnings name, Aurora’s Chief Corporate Officer Cam Battley mentioned “we need better retail infrastructure across the country to see the level of sale everyone is anticipating. It will take a couple more quarters.”

Since legalization in Canada, Aurora’s inventory has declined virtually 35 p.c, following on a pre-legalization sector-wide increase for pot shares. Currently, the inventory is buying and selling at $9.46, up $0.32 from yesterday’s shut.

Source link